223 related articles for article (PubMed ID: 19014680)
41. ENaC Dysregulation Through Activation of MEK1/2 Contributes to Impaired Na+ Absorption in Lymphocytic Colitis.
Barmeyer C; Erko I; Fromm A; Bojarski C; Loddenkemper C; Dames P; Kerick M; Siegmund B; Fromm M; Schweiger MR; Schulzke JD
Inflamm Bowel Dis; 2016 Mar; 22(3):539-47. PubMed ID: 26658215
[TBL] [Abstract][Full Text] [Related]
42. Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway.
Duhamel S; Girondel C; Dorn JF; Tanguay PL; Voisin L; Smits R; Maddox PS; Meloche S
Cell Cycle; 2016 Jun; 15(12):1631-42. PubMed ID: 27152455
[TBL] [Abstract][Full Text] [Related]
43. Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer.
Queralt B; Cuyàs E; Bosch-Barrera J; Massaguer A; de Llorens R; Martin-Castillo B; Brunet J; Salazar R; Menendez JA
Oncotarget; 2016 Dec; 7(50):82185-82199. PubMed ID: 27636997
[TBL] [Abstract][Full Text] [Related]
44. The Endosomal Protein CEMIP Links WNT Signaling to MEK1-ERK1/2 Activation in Selumetinib-Resistant Intestinal Organoids.
Duong HQ; Nemazanyy I; Rambow F; Tang SC; Delaunay S; Tharun L; Florin A; Büttner R; Vandaele D; Close P; Marine JC; Shostak K; Chariot A
Cancer Res; 2018 Aug; 78(16):4533-4548. PubMed ID: 29915160
[TBL] [Abstract][Full Text] [Related]
45. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.
Zheng CF; Guan KL
J Biol Chem; 1993 May; 268(15):11435-9. PubMed ID: 8388392
[TBL] [Abstract][Full Text] [Related]
46. [Mek1 and Mek2 functions in the formation of the blood placental barrier].
Nadeau V; Bissonauth V; Charron J
Med Sci (Paris); 2012 Apr; 28(4):409-15. PubMed ID: 22549869
[TBL] [Abstract][Full Text] [Related]
47. Direct binding of MEK1 and MEK2 to AKT induces Foxo1 phosphorylation, cellular migration and metastasis.
Procaccia S; Ordan M; Cohen I; Bendetz-Nezer S; Seger R
Sci Rep; 2017 Feb; 7():43078. PubMed ID: 28225038
[TBL] [Abstract][Full Text] [Related]
48. MEK1 is required for the development of NRAS-driven leukemia.
Nowacka JD; Baumgartner C; Pelorosso C; Roth M; Zuber J; Baccarini M
Oncotarget; 2016 Dec; 7(49):80113-80130. PubMed ID: 27741509
[TBL] [Abstract][Full Text] [Related]
49. IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas.
Wang Q; Zhang Y; Zhu J; Zheng H; Chen S; Chen L; Yang HS
Signal Transduct Target Ther; 2020 Aug; 5(1):153. PubMed ID: 32843616
[TBL] [Abstract][Full Text] [Related]
50. MEK1 and MEK2, different regulators of the G1/S transition.
Ussar S; Voss T
J Biol Chem; 2004 Oct; 279(42):43861-9. PubMed ID: 15284233
[TBL] [Abstract][Full Text] [Related]
51. Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2.
Chen L; Necela BM; Su W; Yanagisawa M; Anastasiadis PZ; Fields AP; Thompson EA
J Biol Chem; 2006 Aug; 281(34):24575-87. PubMed ID: 16815847
[TBL] [Abstract][Full Text] [Related]
52. MEK1/2 overactivation can promote growth arrest by mediating ERK1/2-dependent phosphorylation of p70S6K.
Guégan JP; Ezan F; Gailhouste L; Langouët S; Baffet G
J Cell Physiol; 2014 Jul; 229(7):903-15. PubMed ID: 24501087
[TBL] [Abstract][Full Text] [Related]
53. A proline-rich sequence unique to MEK1 and MEK2 is required for raf binding and regulates MEK function.
Catling AD; Schaeffer HJ; Reuter CW; Reddy GR; Weber MJ
Mol Cell Biol; 1995 Oct; 15(10):5214-25. PubMed ID: 7565670
[TBL] [Abstract][Full Text] [Related]
54. Mutation analysis of BRAF, MEK1 and MEK2 in 15 ovarian cancer cell lines: implications for therapy.
Estep AL; Palmer C; McCormick F; Rauen KA
PLoS One; 2007 Dec; 2(12):e1279. PubMed ID: 18060073
[TBL] [Abstract][Full Text] [Related]
55. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
Tsai J; Qiu W; Kohen-Avramoglu R; Adeli K
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
[TBL] [Abstract][Full Text] [Related]
56. Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer.
Nicoś M; Krawczyk P; Jarosz B; Sawicki M; Michnar M; Trojanowski T; Milanowski J
Clin Transl Oncol; 2016 Oct; 18(10):1039-43. PubMed ID: 26860843
[TBL] [Abstract][Full Text] [Related]
57. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
Lee CS; Dykema KJ; Hawkins DM; Cherba DM; Webb CP; Furge KA; Duesbery NS
PLoS One; 2011 Feb; 6(2):e17165. PubMed ID: 21365009
[TBL] [Abstract][Full Text] [Related]
58. TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.
Trobridge P; Knoblaugh S; Washington MK; Munoz NM; Tsuchiya KD; Rojas A; Song X; Ulrich CM; Sasazuki T; Shirasawa S; Grady WM
Gastroenterology; 2009 May; 136(5):1680-8.e7. PubMed ID: 19208363
[TBL] [Abstract][Full Text] [Related]
59. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
[TBL] [Abstract][Full Text] [Related]
60. MEK1 regulates pulmonary macrophage inflammatory responses and resolution of acute lung injury.
Long ME; Gong KQ; Eddy WE; Volk JS; Morrell ED; Mikacenic C; West TE; Skerrett SJ; Charron J; Liles WC; Manicone AM
JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31801908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
